← Back to Episodes
PODCAST

Your Dentist Might Know Something About Your Bones Before Your Doctor Does

October 5, 2026·9:12·Episode 138

Quick Summary

This episode covers three research papers relevant to postmenopausal health: a Chinese study on whether a DNA-based cervical screening test performs differently after menopause, a clarification on a vitamin D drug used for bone thinning, and a cross-sectional study on whether dental imaging can flag low bone density before a formal bone scan is ever ordered.

Your Dentist Might Know Something About Your Bones Before Your Doctor Does

0:000:00

Key Takeaways

  • ✦A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
  • ✦Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
  • ✦A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
  • ✦The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
  • ✦All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.